Compumedics Ltd Cash Flow Conversion Efficiency
Compumedics Ltd cash flow conversion efficiency. Based on the latest financial reports, Compumedics Ltd (CMP) has a cash flow conversion efficiency ratio of 0.129x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$2.81 Million ≈ $1.98 Million USD) by net assets (AU$21.82 Million ≈ $15.44 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Compumedics Ltd (2001–2025)
Cash flow conversion efficiency of Compumedics Ltd from 2001 to 2025. This chart illustrates how Compumedics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Compumedics Ltd stock price today for real-time trading data and today's change.
Compumedics Ltd Cash Flow Conversion Ratio Explained
Compumedics Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Compumedics Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Compumedics Ltd ranked by their cash flow conversion efficiency. Also see CMP stock market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Cemat A/S
CO:CEMAT
|
0.066x |
|
KB No.2 Special Purpose Acq
KQ:192250
|
-0.002x |
|
Dominari Holdings Inc.
NASDAQ:DOMH
|
-0.452x |
|
Risma Systems AS
CO:RISMA
|
0.209x |
|
Prime Financial Group Ltd
AU:PFG
|
0.036x |
|
Network-1 Technologies Inc
NYSE MKT:NTIP
|
-0.003x |
|
Desert Gold Ventures Inc
V:DAU
|
-1.378x |
|
Gemvaxlink Co. Ltd
KQ:064800
|
0.009x |
Annual Cash Flow Conversion Efficiency for Compumedics Ltd (2001–2025)
The table below shows the annual cash flow conversion efficiency of Compumedics Ltd from 2001 to 2025. Review cash generation quality of Compumedics Ltd to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$21.82 Million ≈ $15.44 Million |
AU$681.00K ≈ $481.85K |
0.031x | -71.60% |
| 2024-06-30 | AU$18.21 Million ≈ $12.88 Million |
AU$2.00 Million ≈ $1.42 Million |
0.110x | +4001.92% |
| 2023-06-30 | AU$18.29 Million ≈ $12.94 Million |
AU$49.00K ≈ $34.67K |
0.003x | -98.08% |
| 2022-06-30 | AU$23.59 Million ≈ $16.69 Million |
AU$3.29 Million ≈ $2.33 Million |
0.139x | +133.15% |
| 2021-06-30 | AU$22.16 Million ≈ $15.68 Million |
AU$1.32 Million ≈ $936.81K |
0.060x | -75.80% |
| 2020-06-30 | AU$21.79 Million ≈ $15.42 Million |
AU$5.38 Million ≈ $3.81 Million |
0.247x | +31.37% |
| 2019-06-30 | AU$27.32 Million ≈ $19.33 Million |
AU$5.14 Million ≈ $3.63 Million |
0.188x | +678.97% |
| 2018-06-30 | AU$23.16 Million ≈ $16.39 Million |
AU$559.00K ≈ $395.53K |
0.024x | -43.99% |
| 2017-06-30 | AU$20.05 Million ≈ $14.19 Million |
AU$864.00K ≈ $611.34K |
0.043x | -71.82% |
| 2016-06-30 | AU$14.60 Million ≈ $10.33 Million |
AU$2.23 Million ≈ $1.58 Million |
0.153x | -21.75% |
| 2015-06-30 | AU$11.27 Million ≈ $7.97 Million |
AU$2.20 Million ≈ $1.56 Million |
0.195x | +161.00% |
| 2014-06-30 | AU$9.16 Million ≈ $6.48 Million |
AU$686.00K ≈ $485.39K |
0.075x | +52.92% |
| 2013-06-30 | AU$8.35 Million ≈ $5.91 Million |
AU$409.00K ≈ $289.39K |
0.049x | -67.21% |
| 2012-06-30 | AU$9.21 Million ≈ $6.52 Million |
AU$1.38 Million ≈ $973.61K |
0.149x | +824.18% |
| 2011-06-30 | AU$12.76 Million ≈ $9.02 Million |
AU$-263.00K ≈ $-186.09K |
-0.021x | -155.39% |
| 2010-06-30 | AU$12.20 Million ≈ $8.63 Million |
AU$454.00K ≈ $321.23K |
0.037x | -90.65% |
| 2009-06-30 | AU$11.48 Million ≈ $8.12 Million |
AU$4.57 Million ≈ $3.23 Million |
0.398x | +81.71% |
| 2008-06-30 | AU$8.51 Million ≈ $6.02 Million |
AU$1.86 Million ≈ $1.32 Million |
0.219x | +78.76% |
| 2007-06-30 | AU$6.91 Million ≈ $4.89 Million |
AU$847.00K ≈ $599.31K |
0.123x | +159.71% |
| 2006-06-30 | AU$6.72 Million ≈ $4.75 Million |
AU$-1.38 Million ≈ $-975.02K |
-0.205x | -423.10% |
| 2005-06-30 | AU$9.35 Million ≈ $6.61 Million |
AU$-366.59K ≈ $-259.39K |
-0.039x | -120.80% |
| 2004-06-30 | AU$13.95 Million ≈ $9.87 Million |
AU$2.63 Million ≈ $1.86 Million |
0.189x | -25.53% |
| 2003-06-30 | AU$11.68 Million ≈ $8.26 Million |
AU$2.96 Million ≈ $2.09 Million |
0.253x | +7762.90% |
| 2002-06-30 | AU$30.23 Million ≈ $21.39 Million |
AU$97.33K ≈ $68.87K |
0.003x | -88.40% |
| 2001-06-30 | AU$32.16 Million ≈ $22.76 Million |
AU$893.11K ≈ $631.93K |
0.028x | -- |
About Compumedics Ltd
Compumedics Limited engages in the research, development, manufacture, and distribution of medical equipment and related technologies in the Americas, Australia, the Asia Pacific, Europe, and the Middle East. It provides sleep diagnostics products, including Somfit/Somfit Pro, a wearable device for collecting patients' physiological data; Somté PSG; Grael PSG; Grael 4K PSG; Falcon PSG; Falcon HST… Read more